Physician profile
Jumin Sunde
NPI 1295051050
$742.43
in general payments reported to CMS, 2019-2025
11 companies · $284 in 2025
The $284 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.46 · 2020: $81.69 · 2021: $14.03 · 2022: $140 · 2023: $53.85 · 2024: $78.56 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $420.90 | 2019-2025 | Vsp System, Vsp Cranial, Na |
| Merck Sharp & Dohme LLC | $67.13 | 2021-2025 | Keytruda |
| Caris Mpi, INC. | $63.31 | 2025 | Mi Cancer Seek |
| Becton, Dickinson and Company | $45.79 | 2025 | Hemosphere |
| Regeneron Healthcare Solutions, INC. | $31.21 | 2024-2025 | Libtayo |
| Sun Pharmaceutical Industries INC. | $23.00 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.91 | 2022 | |
| Recordati_rare_diseases_inc. | $20.75 | 2024 | Sylvant |
| Novartis Pharmaceuticals Corporation | $18.99 | 2024 | |
| Baxter Healthcare | $14.88 | 2025 | |
| Iovance Biotherapeutics, INC. | $14.56 | 2025 | Amtagvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jumin Sunde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.